Ann Surg

1. DONOVAN KF, Lee KC, Ricardo A, Berger N, et al
   Functional Outcomes After Transanal Total Mesorectal Excision (taTME) for Rectal Cancer: Results From the Phase II North American Multicenter Prospective Observational Trial.
   Ann Surg. 2024;280:363-373.
   

   >> Share

   
   

   
   Ann Surg Oncol

2. KOBAYASHI K, Toritani K, Kimura H, Kawashima J, et al
   Differences in Prognosis and Recurrence Patterns Between Ulcerative Colitis-Associated Colorectal Cancer and Sporadic Colorectal Cancer: A Matched-Pair Analysis.
   Ann Surg Oncol. 2024 Sep 7. doi: 10.1245/s10434-024-16158.
   

   >> Share

   
   

   
   BMC Cancer

3. GAMAGE BD, Ranasinghe D, Sahankumari A, Malavige GN, et al
   Metagenomic analysis of colonic tissue and stool microbiome in patients with colorectal cancer in a South Asian population.
   BMC Cancer. 2024;24:1124.
   

   >> Share

   
   
4. ZHU J, Zhi S, Zeng J, Zhou S, et al
   Development and validation of a TRIM27-based nomogram for predicting metachronous liver metastasis and prognosis in postoperative colorectal cancer patients.
   BMC Cancer. 2024;24:1142.
   

   >> Share

   
   

   
   BMC Gastroenterol

5. CHEN JM, He J, Qiu JM, Yang GG, et al
   Netrin-1-CD146 and netrin-1-S100A9 are associated with early stage of lymph node metastasis in colorectal cancer.
   BMC Gastroenterol. 2024;24:308.
   

   >> Share

   
   
6. TAZINKENG NN, Pearlstein EF, Manda-Mapalo M, Adekunle AD, et al
   Incidence and risk factors for colorectal cancer in Africa: a systematic review and meta-analysis.
   BMC Gastroenterol. 2024;24:303.
   

   >> Share

   
   

   
   Br J Cancer

7. BOLAND PM, Mukherjee S, Imanirad I, Vijayvergia N, et al
   TAS-102, Irinotecan, and bevacizumab in pre-treated metastatic colorectal cancer (TABAsCO), a phase II clinical trial.
   Br J Cancer. 2024 Sep 7. doi: 10.1038/s41416-024-02845.
   

   >> Share

   
   

   
   Cancer Res

8. WANG H, Chen J, Chen X, Liu Y, et al
   Cancer-Associated Fibroblasts Expressing Sulfatase 1 Facilitate VEGFA-Dependent Microenvironmental Remodeling to Support Colorectal Cancer.
   Cancer Res. 2024 Sep 9. doi: 10.1158/0008-5472.CAN-23-3987.
   

   >> Share

   
   

   
   Dis Colon Rectum

9. LI Y, Tan L, Chen N, Liu X, et al
   Neoadjuvant Immunotherapy Alone for Patients With Locally Advanced and Resectable Metastatic Colorectal Cancer of dMMR/MSI-H Status.
   Dis Colon Rectum. 2024 Sep 11. doi: 10.1097/DCR.0000000000003290.
   

   >> Share

   
   
10. AREF A, Abdalla A, Bhullar JS, Knoll E, et al
    Perspective on the PROSPECT: The Conundrum of Managing T3n0-N1 Mid and Upper Rectal Cancer.
    Dis Colon Rectum. 2024;67:1229-1231.
    

    >> Share

    
    
11. SHARMA A, Vispute TP, Saklani A
    Robotic Total Pelvic Exenteration.
    Dis Colon Rectum. 2024;67:e1590.
    

    >> Share

    
    
12. LI H, Feng X, Diao D
    Indocyanine Green Fluorescence Imaging-Guided Laparoscopic Right Hemicolectomy With Complete Mesocolic Excision and Central Vascular Ligation and Transvaginal Specimen Extraction.
    Dis Colon Rectum. 2024 Jul 5. doi: 10.1097/DCR.0000000000003349.
    

    >> Share

    
    
13. AGNES A, Peacock O, Manisundaram N, Kim Y, et al
    The Learning Curve for Robotic Lateral Pelvic Lymph Node Dissection for Rectal Cancer: A View From the West.
    Dis Colon Rectum. 2024;67:1281-1290.
    

    >> Share

    
    
14. CHINELLI J, Perez C, Rodriguez G
    Laparoscopic Complete Splenic Flexure Mobilization and D2 Left Colectomy.
    Dis Colon Rectum. 2024;67:e1588-e1589.
    

    >> Share

    
    

    
    Eur J Surg Oncol

15. DUMONT F, Kepenekian V, Passot C, Ezanno-Manasterski AC, et al
    PIPAC in patients with peritoneal metastases from gastrointestinal tract (PIPOX01): An open label, non-comparative phase 1/2 dose escalation and expansion trial.
    Eur J Surg Oncol. 2024;50:108468.
    

    >> Share

    
    
16. RAUWERDINK P, van de Vlasakker VCJ, Wassenaar ECE, Rovers KP, et al
    First-line palliative systemic therapy alternated with oxaliplatin-based pressurized intraperitoneal aerosol chemotherapy for unresectable colorectal peritoneal metastases: A single-arm phase II trial (CRC-PIPAC-II).
    Eur J Surg Oncol. 2024;50:108487.
    

    >> Share

    
    
17. FRUHLING P, Stillstrom D, Holmquist F, Nilsson A, et al
    Change in tissue resistance after irreversible electroporation in liver tumors as an indicator of treatment success - A multi-center analysis with long term follow-up.
    Eur J Surg Oncol. 2024;50:108508.
    

    >> Share

    
    
18. SUN Y, Jiang W, Tang Z, Wang X, et al
    Textbook outcome in low rectal cancer after neoadjuvant chemoradiotherapy: Post hoc analysis of the LASRE randomized clinical trial.
    Eur J Surg Oncol. 2024;50:108519.
    

    >> Share

    
    
19. KAWASHIMA J, Chatzipanagiotou OP, Tsilimigras DI, Khan MMM, et al
    Preoperative and postoperative predictive models of early recurrence for colorectal liver metastases following chemotherapy and curative-intent one-stage hepatectomy.
    Eur J Surg Oncol. 2024;50:108532.
    

    >> Share

    
    
20. XIA L, Xu X, Zhang C, Cao G, et al
    Low pneumoperitoneum pressure on venous thromboembolism in laparoscopic colorectal cancer surgery: A randomized controlled study.
    Eur J Surg Oncol. 2024;50:108672.
    

    >> Share

    
    

    
    Gut

21. IACUCCI M, Santacroce G, Majumder S, Morael J, et al
    Opening the doors of precision medicine: novel tools to assess intestinal barrier in inflammatory bowel disease and colitis-associated neoplasia.
    Gut. 2024 Jun 8:gutjnl-2023-331579. doi: 10.1136/gutjnl-2023-331579.
    

    >> Share

    
    
22. POLYCHRONIDIS G, He MM, Vithayathil M, Knudsen MD, et al
    Risk of colorectal neoplasia after removal of conventional adenomas and serrated polyps: a comprehensive evaluation of risk factors and surveillance use.
    Gut. 2024;73:1675-1683.
    

    >> Share

    
    
23. MANDARINO FV, Medas R, Gauci JL, Kerrison C, et al
    Endoscopic mucosal resection for large non-pedunculated colorectal polyps: staying on track with a safe, effective and cost-efficient technique.
    Gut. 2024;73:e13.
    

    >> Share

    
    

    
    Int J Cancer

24. NG L, Sin RW, Cheung DH, Wong CK, et al
    Identification and evaluation of a serum microRNA panel to diagnose colorectal cancer patients.
    Int J Cancer. 2024 Sep 8. doi: 10.1002/ijc.35175.
    

    >> Share

    
    

    
    J Surg Oncol

25. HU Q, Yang X
    Impact of Comprehensive Geriatric Assessment on Treatment Strategies and Complications in Older Adults With Colorectal Cancer Considering Surgery.
    J Surg Oncol. 2024 Sep 10. doi: 10.1002/jso.27892.
    

    >> Share

    
    

    
    Oncogene

26. CHURCHHOUSE AMD, Billard CV, Suzuki T, Pohl SOG, et al
    Loss of DOCK2 potentiates Inflammatory Bowel Disease-associated colorectal cancer via immune dysfunction and IFNgamma induction of IDO1 expression.
    Oncogene. 2024 Sep 7. doi: 10.1038/s41388-024-03135.
    

    >> Share

    
    

    
    PLoS One

27. MONTAGNON E, Cerny M, Hamilton V, Derennes T, et al
    Radiomics analysis of baseline computed tomography to predict oncological outcomes in patients treated for resectable colorectal cancer liver metastasis.
    PLoS One. 2024;19:e0307815.
    

    >> Share

    
    
28. PERRIN ML, Bassetti C, Durand Fontanier S, Yardin C, et al
    Effects of HyaRegen gel on tumour proliferation of colorectal peritoneal metastases.
    PLoS One. 2024;19:e0307965.
    

    >> Share

    
    
29. HEZI H, Shats D, Gurevich D, Maruvka YE, et al
    Exploring the interplay between colorectal cancer subtypes genomic variants and cellular morphology: A deep-learning approach.
    PLoS One. 2024;19:e0309380.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share